THIS ANNOUNCEMENT CONTAINS
INSIDE INFORMATION FOR THE PURPOSES OF REGULATION 11 OF THE MARKET
ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310
26
September 2024
SulNOx Group
Plc (the "Company" or "SulNOx")
Granting of Share
Options
Issue of
Shares
(Aquis Stock Exchange:
SNOX)
Granting of Share Options
The board of directors of the
Company (the "Board")
announces that it yesterday granted share options to a director and
certain employees and consultants. Part of these options grants are
under an Enterprise Management Incentive scheme and part under an
unapproved share option scheme. A total of 980,000 options
(the "Options") have been
granted for ordinary shares of 2 pence each in the capital of the
Company ("Ordinary
Shares"), all with a 10-year life.
530,000 of the Options have been
granted with an exercise price of 40.0p, a small premium to the
average closing price at which the Ordinary Shares traded for the
last five days of 37.7 pence. 250,000 of these Options vest
immediately, with the remainder subject to various vesting
conditions. 250,000 of the Options have been granted with an
exercise price of 36.0p, under an existing contractual arrangement,
which includes certain vesting conditions. The remaining 200,000
Options have been granted with an exercise price of 45.0p, all with
vesting conditions.
Issue of Shares to Consultants
The Company has issued a total of
44,788 new Ordinary Shares in settlement of invoices from
consultants, made as follows:
·
20,979 Ordinary Shares at a price of 35.75 pence
per Ordinary Share in settlement of a liability of £7,500.00;
and
·
23,809 Ordinary Shares at a price of 31.50 pence
per Ordinary Share in settlement of a liability of
£7,500.00.
The prices of the above issues have
been calculated on the average share price for the period of time
over which the services were delivered and the terms of the
consultants' contracts. An application will be made to admit
the new Ordinary Shares for trading on AQSE Growth Market, which is
anticipated to occur on or around 2 October 2024 ("Admission").
On Admission, the Company will have 121,550,946
Ordinary Shares in issue, each with one voting right. The Company
does not hold any shares in treasury and therefore the total number
of voting rights in the Company is 121,550,946. This figure should
be used by shareholders from Admission as the denominator for the
calculations by which they will determine if they are required to
notify their interest in, or a change to their interest in the
Company under the FCA's Disclosure Guidance and Transparency
Rules.
- Ends -
For further information please
contact:
|
SulNOx Group plc
Steven
Cowin, CFO
|
Tel: 07624 491 821
|
|
|
|
|
Allenby Capital Limited
(AQSE Corporate Adviser)
Nick Harriss / John
Depasquale
|
Tel: 020 3328 5656
|
|
1
|
Details of the person discharging
managerial responsibilities / person closely associated
|
|
a)
|
Name
|
Alex Albertini
|
|
2
|
Reason for notification
|
|
a)
|
Position / status
|
NED
|
|
b)
|
Initial
notification/Amendment
|
Initial Notification
|
|
3
|
Details of the
issuer, emission allowance market participant,
auction platform, auctioneer or
auction monitor
|
|
a)
|
Name
|
SulNOx Group plc
|
|
b)
|
LEI
|
21380011EU95E93AQN91
|
|
4
|
Details
of the transaction(s):
section to be repeated for (i) each type
of instrument; (ii) each type
of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
|
|
a)
|
Description of the financial
instrument, type of instrument
Identification code
|
Ordinary Shares of 2 pence
each
ISIN: GB00BJVQQP66
|
|
|
Nature of the transaction
|
Grant of share options, subject to a
market price of 50p at the time of exercise
|
|
c)
|
Price(s) and volumes(s)
|
|
Price(s)
|
Volume(s)
|
|
40p
|
250,000
|
|
|
d)
|
Aggregated information
Aggregated volume
Price
|
N/A
|
|
e)
|
Date of the transaction
|
26 September 2024
|
|
f)
|
Place of the transaction
|
N/A
|